Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
SDTM modelling: from study protocol to SDTM-compliant datasets
1. SDTM MODELLING: FROM STUDY
PROTOCOL TO SDTM-COMPLIANT
DATASETS
- Biometristi Italiani Associati – Seminario BIAS
CDISC SDTM and ADaM: Moving from theory to practice
SAS Institute – Milano - 14/03/2014
Angelo Tinazzi
Cytel Inc., Wilmington Del. USA
Succursale de Meyrin – Geneva – Switzerland
angelo.tinazzi@cytel.com
2. Cytel Inc. - Confidential 2[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS
DATASETS
Disclaimer
The information contained in this
presentation is based on personal
research of the author and does not
necessarily represent Cytel Inc..
3. Cytel Inc. - Confidential 3[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Let’s migrate
Phase III study
First Relapsed or Refractory Acute Myeloid
Leukemia
Two arms - Blinded study
Case Study
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
4. Cytel Inc. - Confidential 4[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Let’s migrate
Prior and “follow-up” cancer treatment
Tumor Response (efficacy) including
response to prior therapies
Combination Therapies
Follow-up
Other various findings
Main Data Challenges
SDTM IG V 3.1.2 with Amendment 1 was used
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
5. Cytel Inc. - Confidential 5[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration Approach
Gap analysis
Understanding source datasets
Modelling the Migration
Migration
Finalize, Validate and Document
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
6. Cytel Inc. - Confidential 6[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Gap Analysis
Initiated prior to commencing migration activities
How to perform gap analysis
Itemization and evaluation of files to support migration activities
Document inventory
Study documents
CDISC Standards
Company Standards / Company Implementation Guidance
Validate sample CRF fields versus source data
External data requirements e.g. central labs
Comparison of protocol amendments/versions against CRF
versions
Clarifies the scope and challenges of migration activities
Identifies differences in data collection formats
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
7. Cytel Inc. - Confidential 7[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Understanding Source Datasets
Determine if data
Need to be submitted (e.g. «Any AE» information)
Can be used as it is (structure-wise)
Needs to be transposed and brought to a normalized
structure
Need detailed pre-processing
Validate the data for any missing/partial values
e. g. format of date variable
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
8. Cytel Inc. - Confidential 8[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Understanding Source Datasets
Data domains first ‘pruning’
AE
AEAER CMCMR
CMPR
PRAML
BPP
CG
NLMU
LVEF
MARA
VS
PMBSAIFVPR
IFCRE
NCNC
NPTN
SCT
EG
PE
SS
RESP
LB
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
Events Findings Interventions Special Domains
ET
CD
RA
PRA
MLTX
RD
CD
RA
PRA
MLTX
RD
9. Cytel Inc. - Confidential 9[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Understanding Source Datasets
Data domains first ‘pruning’ – Multiple sources
SDTM Raw Datasets
AE AE AEAER
CM CMCMR CMPRIOR PRAML BPP
DM DEMO SCEL DS
DS DEMO DS RD ET
EX IFVPR IFCRE
IE IE (only violated criteria)
MH MH CH PSC DX
VS VS PMBSA
YG NCNC NPTN SCT
ZG CG MARA LVEF NLMU
ZR PRAMLTX CD RD RA
VS VS PMBSA
<Not submitted> ETH
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
10. Cytel Inc. - Confidential 10[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
The annotated CRF provides the migration team
with a clear presentation of SDTM variables
Completed following the GAP analysis and prior to
migration
Experience needed to create the annotated CRF
Knowledge of the SDTM Implementation Guide and
Metadata Submission Guidelines (chapter 4 – Guidelines for
Annotating CRFs)
Annotated CRF Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
11. Cytel Inc. - Confidential 11[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Upon receiving all required information, start
defining mapping rules.
The mapping rules should be defined from source
datasets (raw data) to target datasets (SDTM)
Key components
SDTM standards and Controlled Terminology files
Study documents including original Annotated CRF
Standard template for specifications
Standard mapping rules to be used (e.g. ISO date
conversion, rename, derive etc.)
Additional Specifications Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
12. Cytel Inc. - Confidential 12[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Adapt study terminology to standard CDISC (NCI)
terminology (CT)
The mapping needs to be described in the define.xml
CT not only restricted to only those values that are
available in the data
All entries capitalized for CDISC CT
‘Spelling’ as per external dictionary (e.g. MedDRA)
Controlled Terminology Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
13. Cytel Inc. - Confidential 13[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Mapping to CDISC (NCI) Controlled Terminology
e.g. Concomitant Medications route
Controlled Terminology Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
Source CDISC/NCI CT
INFUSION PARENTERAL
Administration by injection, infusion, or implantation
MOUTH/THROAT ORAL
Administration to or by way of the mouth
TOPICAL-EYE OPHTHALMIC
TOPICAL PO TOPICAL
14. Cytel Inc. - Confidential 14[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Mapping to CDISC (NCI) Controlled Terminology
e.g. Laboratory Unit
Controlled Terminology Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
CDISC/NCI CT Source
10^9/L X 10 9/L X1000/MM3 X10^3/MM3
10^6/L X10 6/UL X10^3/ML
umol/L MICROMOL/L
15. Cytel Inc. - Confidential 15[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Domain that contains a clear representation of the
design of a clinical trial
Created prior to CRF annotation and data migration
Experience needed to create the trial design data
set:
SDTM Trial Design Concepts
Experience with key clinical documents (e.g. Protocol, SAP,
Data Sets, CSR)
Trial Design Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
16. Cytel Inc. - Confidential 16[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Subject Reference Start (RFSTDTC) / End Date
(RFENDTC)
E.g. first / last dose
Planned (ARM/ARMCD) vs Actual Arm
(ACTARM/ACTARMCD)
DM Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
17. Cytel Inc. - Confidential 17[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Relative to Subject Reference Date (RFSTDTC)
Standard Derivation
Relative Study Days –DY –STDY --ENDY Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
ConclusionsIf (--STDTC<DM.RFSTDTC) then –STDY=--STDTC-DM.RFSTDTC
Else –STDY=(--STDTC-DM.RFSTDTC)+1
SDTM does not allow for Study day 0
18. Cytel Inc. - Confidential 18[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Prior anti-cancer therapies in CM
Mapping Details – Categories in standard domains
The new PR domain available in IG 3.2 may
be used to store Surgery or other procedures
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
19. Cytel Inc. - Confidential 19[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Check that none of the existing published domains
will fit the need
Use existing models as prototype or choose the
appropriate general observation class
How to determine where data belong in the SDTM
IG v3.1.3 section 8.6
Assign a 2–letter domain code. Possible convention:
Z- for findings
Y- for interventions
X- for events
Mapping Details – New Domains Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
20. Cytel Inc. - Confidential 20[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Other Findings (ZG)
Survival Status (ZS)
Tumor Response (ZR)
Other non-protocol cancer therapies (YG)
Mapping Details – New Domains Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
New SS (Subject Status) domain available
in IG 3.2
21. Cytel Inc. - Confidential 21[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Other non-protocol cancer therapies (YG)
Mapping Details – New Domains Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
The Interventions class captures investigational, therapeutic
and other treatments that are administered to the subject
(with some actual or expected physiological effect) either as
specified by the study protocol (e.g., exposure to study drug),
coincident with the study assessment period (e.g.,
concomitant medications), or self-administered by the subject
(such as use of alcohol, tobacco, or caffeine).
SDTM IG v3.1.3 Section 2.4
22. Cytel Inc. - Confidential 22[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Other non-protocol cancer therapies (YG)
Mapping Details – New Domains Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
STUDYID USUBJID DOMAIN YGSEQ YGSPID YGSTDTC YGENDTC
XXXX YYYYYY YG 1 1 2011-01-12 2011-02-20
XXXX YYYYYY YG 2 1 2011-01-12 2011-02-25
YGTRT YGCAT YGSCAT
FTC PLUS SORAFENIB SUBSEQUENT NON-PROTOCOL AML
TREATMENTS
CHEMOTHERAPY
CLAG-M THERAPY SUBSEQUENT NON-PROTOCOL AML
TREATMENTS
CHEMOTHERAPY
Interventions
Qualitfiers
2.2.1
Select and include the relevant Qualifier variables from the
identified general observation
23. Cytel Inc. - Confidential 23[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Other non-protocol cancer therapies (YG)
Mapping Details – New Domains Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
Solicited information in the CRF
24. Cytel Inc. - Confidential 24[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
The Disposition dataset provides an accounting for all subjects who
entered the study and may include protocol milestones, such as
randomization, as well as the subject's completion status or
reason for discontinuation for the entire study or each phase or
segment of the study, including screening and post-treatment
follow-up. Sponsors may choose which disposition events and
milestones to submit for a study. See ICH E3, Section 10.1 for
information about disposition events.
Mapping Details – Disposition (DS)
SDTM IG v3.1.3 Section 6.2.2
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
25. Cytel Inc. - Confidential 25[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Mapping Details – Disposition (DS) Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
Decide what to store in DS
Protocol Milestone vs Disposition Event
26. Cytel Inc. - Confidential 26[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
AE, CM, DM, DS, EX, LB, MH, VS, YG, ZG, ZR, ZR
Domains Requiring Supplemental Qualifier Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
SUPPDM
SUPPCM
27. Cytel Inc. - Confidential 27[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
RELREC
AE <---> CM
ZR <---> CM
ZR <---> YG
Supplemental Qualifier (SUPPXX)
One per each domain where supplemental qualifiers
are required
It should be not used as a waste basket
Identifying Relationship Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
FDA CDER Common Data Standards Issues Document
28. Cytel Inc. - Confidential 28[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Identifying Relationship – ZR vs CM
The link requires also USUBJID (here hiden)
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
ZR contains also tumor response to prior anti-cancer
therapies stored in CM e.g. chemotherapy
29. Cytel Inc. - Confidential 29[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Identifying Relationship – ZR vs CM
CM
RELREC
ZR
The link requires also USUBJID (here hiden)
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
30. Cytel Inc. - Confidential 30[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Because study arms are combining two treatments,
there was the need of collecting relationship and
action taken related to the two drugs. The
experimental drug make use of AEACN and AEREL in
AE, while for the combination drug Supplemental
Qualifiers were required
Identifying Relationship – SUPPAE
The link requires also USUBJID (here hiden)
AE
SUPPAE
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
31. Cytel Inc. - Confidential 31[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
Split Domains if needed (dataset size >1GB)
By Category (--CAT) or sub-category (--SCAT)
e.g. LBCAT in LB (HEMATOLOGY CHEMISTRY, etc.)
Imputations are not allowed in SDTM
e.g. laboratory results such as ‘<50’ assigned to LBORRES
(char variable) while LBORRESN (numeric version) will be
empty assumption for ‘<‘50’ in ADaM
Additional points to consider Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
FDA CDER common data standard issues document
32. Cytel Inc. - Confidential 32[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration
Understanding Specifications
Developing migration programs (e.g. SAS)
Transformation type
Auto
Convert Data Types e.g. numeric to text
Rename
Convert Values e.g. Adaptation of CT
Convert ISODate
Concatenate e.g. in DSTERM main term plus details
Compute (any user-defined SAS® code logic)
Identify derivations common to all domains
e.g. COMVAR temp dataset to store keys, important date
SAS Macros to assist in standardizing the migration process
(e.g. ISO date conversion, Controlled Terminology Look-ups)
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
33. Cytel Inc. - Confidential 33[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration
VSVSVitalsVitals
Source Dataset
Variable
Target Dataset
Variables
VITALS.STUDYID VS.STUDYID Auto
VITALS.USUBJID VS.USUBJID Auto
VITALS.VISITNUM VS.VISITNUM Auto
VITALS.VISIT VS.VISIT Auto
Mapping Logic
Direct Variables Mapping Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
34. Cytel Inc. - Confidential 34[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration
Pre-processing Mapping Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
VSVSVitalsVitals
Source Dataset
Variables
Target Dataset
Variables
VITALS.SYSBP VS.VSTESTCD Transpose- Name Auto
VITALS.DIABP VS.VSTESTCD Transpose- Name Auto
VITALS.PULSE VS.VSTESTCD Transpose- Name Auto
VITALS.RESP VS.VSTESTCD Transpose- Name Auto
VITALS.TEMP VS.VSTESTCD Transpose- Name Auto
VITALS.WEIGHT VS.VSTESTCD Transpose- Name Auto
VITALS.HEIGHT VS.VSTESTCD Transpose- Name Auto
Mapping
Logic
Pre-
processing
38. Cytel Inc. - Confidential 38[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration
Tools to facilitate the mapping - MapGene Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
39. Cytel Inc. - Confidential 39[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Migration
Tools to facilitate the mapping - MapGene Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
40. Cytel Inc. - Confidential 40[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Remove duplicates when it is clear the «Not Done»
applies to a certain category of assessments
Finalize - Final ‘pruning’
SDTM IG v3.1.3 Section 4.1.5.1.2 “TESTS NOT DONE “
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
41. Cytel Inc. - Confidential 41[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Downsize variable length
Variable length should be assigned based on actual
stored data to avoid to minimize file size
Exception for
All variables with identical names in different SDTM
domains e.g. USUBJID, STUDYID, VISIT, EPOCH
--DTC variables (always $19)
Finalize - Final ‘pruning’
H Y P E R K A L E M I A
AETERM
Length=14
H Y P E R K A L E M I A Length=12
“Warning” issued by Validation Check SD1081
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
FDA CDER Common Data Standards Issues Document
42. Cytel Inc. - Confidential 42[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Actual protocol events (SV and SE) from
migrated SDTM
Identify key variables / Sorting
--SEQ generation
Use of special characters
E.g. any ASCII code not within 32-126
Additional within domain consistency
Same LBSTRESU within the same LBCAT LBSPEC
LBMETHOD
Finalize – Additional Steps Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
43. Cytel Inc. - Confidential 43[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
SDTM can be only finalized at the time of db-lock
Unplanned Visits
Numbered based on chronological order
Medical Coding to be completed
Unexpected Controlled Terminology
Laboratory units to harmonize to Controlled Terminology
Free text for Partial Date
XPT Generation
Finalize
Possible “Warning” / “Errors” issued by OpenCDISC
•SD0080 - AE start date is after the latest Disposition date
•SD0081 - Observation date is after the latest Disposition date
•SD0002 - NULL value in AEDECOD variable marked as Required
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
44. Cytel Inc. - Confidential 44[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
QC of Migration of Clinical Data
e.g. double programming and blinded if possible
Compliance to SDTM standards (OpenCDISC)
Re-program of key statistical outputs
e.g. compare outputs created with original raw data and
compare with outputs created from SDTM converted datasets
Validate Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
45. Cytel Inc. - Confidential 45[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
«Justify» errors / warnings
Provide additional instructions / details
Help the reviewer understanding the data structure
Useful ‘hints’ for stats/programming team
!!!! «Original» information may not in the location where you would
expect to be !!!!!
Document - Reviewer Guide Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
46. Cytel Inc. - Confidential 46[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Document - Reviewer Guide Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
47. Cytel Inc. - Confidential 47[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Document - Reviewer Guide
Additional Key Instructions
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
48. Cytel Inc. - Confidential 48[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Finalize, Validate and Document
Document - Reviewer Guide
Document Deviations
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
Unexpected variable for a domain belonging to an
observation class where the variable is allowed
E.g. Severity of Medical History
49. Cytel Inc. - Confidential 49[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Conclusions
ADaM is the right place for «derivation», but actually
migrating to SDTM implies the «shake» of original
source data
Migrating to SDTM is not just a matter of renaming
variables
It could be challenging for biostats sometime to
find / locate the required information
Let’s migrate
Migration Approach
Gap Analysis
Understanding datasets
Modelling the migration
Migration
Finalize, Val, Document
Conclusions
50. Cytel Inc. - Confidential 50[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS
DATASETS
Questions
51. Cytel Inc. - Confidential 51[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Q&A
Q: Does SDTM requires british or american english?
A: Standard NCI terminology should be used, while
for free text original entries should be kept e.g.
investigator specifications
52. Cytel Inc. - Confidential 52[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Q&A
Q: Should study in a submission up-coded to the
same Medical Dictionary version? E.g. MedDRA for
AEs
A: Yes if an ISS (Integrated Safety Summary) is
submitted, then a single version of MedDRA should
be used
FDA CDER Common Data Standards Issues Document
53. Cytel Inc. - Confidential 53[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
TA
Identifying Elements and Trials Arms - PLANNED
TE
54. Cytel Inc. - Confidential 54[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
TV
Identifying Elements and Trials Arms - PLANNED
+TI +TS
55. Cytel Inc. - Confidential 55[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
Modelling the Migration
SV
Identifying Elements and Trials Arms - ACTUAL
SE
56. Cytel Inc. - Confidential 56[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
An example Project
Weeks
W0
CytelClient
W1
Share documents
Annotate CRF
Understanding Study Datasets
Gap Analysis
Submit datasets
Migration
Validation
Provide information
Develop Mapping
specifications
Create Define.XML
Review
Review
Communicate the
results /issues
Confirmation on
specs
Submit
Confirmation on
datasets
Final submission
• Study protocol CY21-
002, CRF, SAP etc.
• Datasets
• Other informative
documents
• Study protocol CY21-
002, CRF, SAP etc.
• Datasets
• Other informative
documents
• Compare source
dataset as against CRF
• Inform in case of
missing documents
• Compare source
dataset as against CRF
• Inform in case of
missing documentsShare required
information
Share required
information
W2
W3
W4
W5
57. Cytel Inc. - Confidential 57[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
An example Project
Weeks CytelClient
Share documents
Annotate CRF
Understanding Study Datasets
Gap Analysis
Submit datasets
Migration
Validation
Provide information
Develop Mapping
specifications
Create Define.xml
Review
Review
Communicate the
results /issues
Confirmation on
specs
Submit
Confirmation on
datasets
Final submission
W0
W1
W2
W3
W4
W5
58. Cytel Inc. - Confidential 58[A. Tinazzi]
SDTM MODELLING: FROM STUDY PROTOCOL TO COMPLIANTS DATASETS
An example Project
Weeks CytelClient
Share documents
Annotate CRF
Understanding Study Datasets
Gap Analysis
Submit datasets
Migration
Validation
Provide information
Develop Mapping
specifications
Create Define.xml
Review
Review
Communicate the
results /issues
Confirmation on
specs
Submit
Confirmation on
datasets
Final submission
Receive specs approvalReceive specs approval
• Develop and validate datasets as
listed in the scope document
• Submit
- Datasets
- SAS programs
- Support documents
• Develop and validate datasets as
listed in the scope document
• Submit
- Datasets
- SAS programs
- Support documents
Receive Confirmation on
datasets
Receive Confirmation on
datasets
Create Define document
and submit all
deliverables
Create Define document
and submit all
deliverables
W0
W1
W2
W3
W4
W5
Editor's Notes
Protocol Milestone indicates a protocol-specific point-in-time event
Disposition event indicates the completion of the study as a whole, or the end of the current Epoch if the Epoch variable is populated